Ms. Oliwia Kordyl | Microneedle Systems | Best Research Article Award

Ms. Oliwia Kordyl | Microneedle Systems | Best Research Article Award

Ms. Oliwia Kordy, Poznan University of Medical Sciences, Poland

Ms. Oliwia Kordyl is a passionate biomedical researcher and Ph.D. candidate at Poznan University of Medical Sciences, Poland. Her research focuses on microneedle systems for localized drug delivery, particularly for treating skin infections and depressive disorders. With a background in biotechnology and a hands-on approach to molecular biology, Ms. Kordyl has gained practical expertise in 3D printing, drug permeability testing, and ex vivo assessments. Her work combines advanced pharmaceutical technology with molecular research, aiming to enhance transdermal therapeutic systems. Previously, she served in various roles from lab manager to molecular biologist, contributing to genetic, microbiological, and drug delivery research. Her interdisciplinary work bridges innovation in medical technology with therapeutic solutions. 🧫🧬

Professional Profile 

Orcid

🏅 Suitability for Best Researcher Award 

Ms. Oliwia Kordyl is a strong contender for the Best Researcher Award due to her innovative contributions in microneedle-based drug delivery systems and molecular biotechnology. Her cutting-edge work integrates 3D printing with pharmaceutical applications, addressing urgent needs in localized treatments and transdermal drug delivery. She has consistently demonstrated excellence in experimental design, pharmaceutical analysis, and research dissemination at international platforms. Her projects funded by the National Science Centre of Poland highlight her competence in conducting high-impact research. Oliwia’s ability to combine academic excellence with technical expertise makes her a valuable researcher whose work is already influencing future directions in medical technology and personalized drug delivery systems. 🧠💊🖨️

🎓 Education 

Ms. Kordyl began her academic journey at K.K. Baczyński Secondary School, specializing in biology, physics, and chemistry. She earned both her Bachelor’s and Master’s degrees in Biotechnology from Adam Mickiewicz University, Poznań. Her Bachelor’s thesis focused on global methylation (5mC) and hydroxymethylation (5hmC) in sperm DNA of oligozoospermic males, while her Master’s thesis investigated Fam71f1 gene expression in a mouse model of spermatogenesis. In November 2023, she commenced her Ph.D. at Poznan University of Medical Sciences, focusing on 3D-printed microneedles for targeted drug delivery. Her education reflects a rich blend of molecular biology, biotechnology, and medical technology, equipping her with a unique skill set in experimental therapeutics and epigenetics. 🧬📚🔍

🧪 Experience

Ms. Kordyl has held various technical and research roles across academia and industry. She currently works as a Lab Manager at Poznan University of Medical Sciences, overseeing a project on 3D-printed microneedles for depressive disorders. Previously, she was a Molecular Biologist at BGW Research Center, where she specialized in genome editing (CRISPR), PCR, and yeast hybridization. Her earlier experience at ALAB laboratoria involved qPCR-based SARS-CoV-2 detection. Additionally, she has contributed to epigenetic research at the Institute of Human Genetics and worked in clinical settings as a Medical Admissions Clerk. Her diverse experience showcases her hands-on proficiency in molecular biology, microbiology, and biomedical research, making her a versatile and skilled young researcher. 🧫🧑‍🔬🧪

🏆 Awards and Honors 

Ms. Kordyl has presented her research at leading international conferences, earning recognition for her work in epigenetics and reproductive biology. She delivered talks at events such as the 21st European Testis Workshop (Barcelona) and the Polish Society of Andrology conference, where she discussed chromatin integrity and methylation in oligozoospermia. Her research posters were featured at the 36th Annual ESHRE Meeting and the European Human Genetics Virtual Conference, showcasing advanced immunostaining and epigenetic localization in sperm chromatin. These honors reflect her commitment to scientific excellence and her growing impact in the biomedical field. Her communication skills and scientific rigor have helped elevate Poland’s presence in epigenetics and pharmaceutical technology. 🧬📜🎤

🔍 Research Focus 

Ms. Kordyl’s research interests lie at the intersection of medical technology, biotechnology, and pharmaceutical delivery systems. She specializes in developing microneedle-based drug delivery platforms for treating localized skin infections and mental health conditions. Her doctoral project involves optimizing microneedle production and evaluating physicochemical and pharmaceutical properties both in vitro and ex vivo. She also explores epigenetic regulation in reproductive biology, including DNA methylation and histone modification. Previous work includes advanced molecular biology (PCR, CRISPR, cloning) and fermentation science using metabolic CO₂. Oliwia’s holistic approach brings together molecular biology, bioengineering, and pharmacology, contributing toward the development of targeted, non-invasive therapeutic technologies with real-world clinical applications. 💉🧬🧠

Publication Top Notes

  • Optimization of LCD-Based 3D Printing for the Development of Clotrimazole-Coated Microneedle Systems

    • Year: 2025
  • Microneedle-Based Arrays – Breakthrough Strategy for the Treatment of Bacterial and Fungal Skin Infections

    • Year: 2025
  • Microneedle System Coated with Hydrogels Containing Protoporphyrin IX for Potential Application in Pharmaceutical Technology

    • Year: 2024
  • Global 5mC and 5hmC DNA Levels in Human Sperm Subpopulations with Differentially Protaminated Chromatin in Normo- and Oligoasthenozoospermic Males

    • Year: 2022

 

 

Assoc. Prof. Dr. Marta Slavkova | Pharmaceutical Technology | Best Researcher Award

Assoc. Prof. Dr. Marta Slavkova | Pharmaceutical Technology | Best Researcher Award

Assoc. Prof. Dr. Marta Slavkova, Medical University of Sofia, Bulgaria

Assoc. Prof. Dr. Marta Slavkova is an esteemed pharmaceutical researcher specializing in Pharmaceutical Technology and Biopharmacy. With a Ph.D. and ongoing specialization in Toxicology and Toxicological Analysis, she has made significant contributions to nanoparticulate drug delivery systems. Her research focuses on improving chemotherapeutics’ efficacy while reducing off-target effects. She has been a DAAD scholar in Düsseldorf, Germany, and has actively participated in international conferences. As a reviewer for WOS-indexed journals, she plays a crucial role in scientific advancements. Fluent in English and German, she teaches master’s students in Pharmaceutical Technology and continues to explore innovative drug delivery systems.

🌍 Professional Profile:

Google Scholar

Orcid

Scopus

🏆 Suitability for Best Researcher Award

Dr. Slavkova’s research in Medical and Pharmaceutical Technology, particularly in nanoparticulate drug delivery systems, showcases groundbreaking advancements in drug targeting and biopharmaceutical characterization. Her expertise in developing novel nanocarriers, including mesoporous silica and lipid-based nanoparticles, enhances therapeutic efficacy and safety. Her international collaborations, DAAD research scholarship, and extensive publication record make her a distinguished candidate for the Best Researcher Award. With hands-on experience in ISO quality standards, manuscript reviewing for WOS-indexed journals, and active participation in global conferences, Dr. Slavkova is an influential researcher dedicated to the progress of pharmaceutical sciences.

🎓 Education 

Dr. Slavkova earned her Ph.D. in Pharmaceutical Technology with a specialization in Biopharmacy. She is currently advancing her expertise in Toxicology and Toxicological Analysis. Her academic achievements include a DAAD scholarship for a 10-month research grant in Düsseldorf, Germany (2014-2015). Additionally, she has completed an auditor course in ISO 9001:2015 and ISO 19011:2018, equipping her with quality management expertise. Her extensive education and professional training allow her to bridge scientific research with industry standards. Fluent in English and German, she integrates international knowledge into her research and teaching, further strengthening her academic and professional profile.

👨‍🏫 Experience

Dr. Slavkova is an experienced researcher and academic, currently engaged in nanoparticulate drug delivery systems. She teaches Pharmaceutical Technology to master’s students and contributes significantly to pharmaceutical research. Her work includes developing novel drug carriers for parenteral, dermal, and oral applications, particularly for chemotherapeutics and natural bioactive compounds. She has participated in multiple international conferences, presenting her findings on improving drug efficacy and minimizing side effects. As a reviewer for WOS-indexed journals, she evaluates cutting-edge research, ensuring the highest quality standards. Her background in ISO auditing adds another layer of expertise to her scientific and professional endeavors.

🏅 Awards and Honors 

Dr. Slavkova has received numerous accolades for her contributions to pharmaceutical research. She was awarded a prestigious DAAD scholarship for a research grant in Düsseldorf, Germany (2014-2015). She has been an invited speaker at various international conferences, showcasing her expertise in nanoparticle drug delivery systems. Her active role as a reviewer for high-impact WOS-indexed journals highlights her influence in the scientific community. Additionally, she has been recognized for her contributions to pharmaceutical education, mentoring master’s students in advanced pharmaceutical technologies. Her interdisciplinary approach to drug delivery research has earned her recognition from both academic and industry professionals.

🔬 Research Focus 

Dr. Slavkova’s research revolves around nanoparticulate drug delivery systems, targeting various administration routes such as parenteral, dermal, and oral. She specializes in mesoporous silica nanoparticles, polymer nanoparticles, lipid nanocarriers, and hybrid nanoparticle systems. Her work aims to enhance chemotherapeutic efficacy while reducing systemic toxicity. Additionally, she investigates the biomedical potential of natural compounds like curcumin, quercetin, and berberine. Her expertise in biopharmaceutical characterization allows her to develop innovative drug targeting methods. With a strong focus on medical and pharmaceutical technology, her research contributes to the advancement of precision medicine and targeted therapies.

📖 Publication Top Notes

  • Orodispersible Drug Formulations for Children and Elderly

    • Year: 2015
    • Citations: 268
  • Gel Formulations for Topical Treatment of Skin Cancer: A Review

    • Year: 2023
    • Citations: 32
  • Superior Proapoptotic Activity of Curcumin-Loaded Mixed Block Copolymer Micelles with Mitochondrial Targeting Properties

    • Year: 2018
    • Citations: 21
  • A Novel Approach for Fabricating Nanocomposite Materials by Embedding Stabilized Core-Shell Micelles into Polysaccharide Cryogel Matrix

    • Year: 2018
    • Citations: 20
  • 10 Years EU Regulation of Pediatric Medicines–Impact on Cardiovascular Drug Formulations

    • Year: 2018
    • Citations: 14